Gala Pharmaceutical Inc. Stock-Based Compensation
Gala Pharmaceutical Inc. reported Stock-Based Compensation of $0 for the 12-month period ending 2017-11-30, per its 10-K filed 2018-04-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2018-04-06
- Gala Pharmaceutical Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-11-30 was $0.00.
- Gala Pharmaceutical Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-08-31 was -$80.63K.
- Gala Pharmaceutical Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-05-31 was $80.63K.
- Gala Pharmaceutical Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-02-28 was $0.00, a 100.00% decline year-over-year.
- Gala Pharmaceutical Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Gala Pharmaceutical Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $17.50K, a 90.69% decline from fiscal 2015.
- Gala Pharmaceutical Inc. share-based payment arrangement, noncash expense for fiscal 2015 was $188.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2017-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-06 | -$80.63K derived: sum of 2 quarters · filed 2018-04-06 | $0.00 derived: sum of 3 quarters · filed 2018-04-06 | $0.00 10-K · filed 2018-04-06 |
| 2017-08-31 | -$80.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $0.00 derived: sum of 2 quarters · filed 2017-10-19 | $0.00 10-Q · filed 2017-10-19 | $0.00 derived: sum of 4 quarters · filed 2018-04-06 |
| 2017-05-31 | $80.63K 10-Q · filed 2017-07-28 | $80.63K 10-Q · filed 2017-07-28 | $80.63K derived: sum of 3 quarters · filed 2018-04-06 | $80.63K derived: sum of 4 quarters · filed 2018-04-06 |
| 2017-02-28 | $0.00 10-Q · filed 2017-04-18 | $0.00 derived: sum of 2 quarters · filed 2018-04-06 | $0.00 derived: sum of 3 quarters · filed 2018-04-06 | $0.00 derived: sum of 4 quarters · filed 2018-04-06 |
| 2016-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-06 | $0.00 derived: sum of 2 quarters · filed 2018-04-06 | $0.00 derived: sum of 3 quarters · filed 2018-04-06 | $17.50K 10-K · filed 2018-04-06 |
| 2016-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $0.00 derived: sum of 2 quarters · filed 2017-10-19 | $17.50K 10-Q · filed 2017-10-19 | -$65.50K derived: sum of 4 quarters · filed 2017-10-19 |
| 2016-05-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-15 | $17.50K 10-Q · filed 2016-07-15 | -$65.50K derived: sum of 3 quarters · filed 2017-04-18 | -$65.50K derived: sum of 4 quarters · filed 2017-04-18 |
| 2016-02-29 | $17.50K 10-Q · filed 2017-04-18 | -$65.50K derived: sum of 2 quarters · filed 2017-04-18 | -$65.50K derived: sum of 3 quarters · filed 2017-04-18 | -$21.95K derived: sum of 4 quarters · filed 2017-04-18 |
| 2015-11-30 | -$83.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-03-23 | -$83.00K derived: sum of 2 quarters · filed 2017-03-23 | -$39.45K derived: sum of 3 quarters · filed 2017-03-23 | $188.00K 10-K/A · filed 2017-03-23 |
| 2015-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $43.55K derived: sum of 2 quarters · filed 2016-11-04 | $271.00K 10-Q · filed 2016-11-04 | |
| 2015-05-31 | $43.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-15 | $271.00K 10-Q · filed 2016-07-15 | ||
| 2015-02-28 | $227.45K 10-Q · filed 2016-05-10 |